Probably, CXCR2 positive ovarian cancer cells could potentiate the NF-κB mediated CCL20 in proinflammatory tumor microenvironment via interaction between ovarian cancer and cancer-associated stromal cells compared to CXCR2 negative cells (Fig 6D). Here, CCL20 is linked to ovarian cancer.